Is Restoration Hardware Holdings (RH) Outperforming Other Retail-Wholesale Stocks This Year?
China Life Insurance Co. Ltd’s LFC) net profit attributable to equity holders was $5.1 billion (RMB 32.2 billion) at the end of 2017, reflecting 68.6% year-over-year growth. The upside was primarily driven by higher revenues.
For 2017, the company generated total revenues of $103 billion (RMB 643.4 billion), an increase of 19% year over year.
The company’s gross written premium was $82 billion (RMB 512 billion), up 19% year over year.
The company's gross investment income was $20.6 billion (RMB 129 billion), a 19% rise year over year.
China Life Insurance Company Limited Price, Consensus and EPS Surprise
China Life Insurance Company Limited Price, Consensus and EPS Surprise | China Life Insurance Company Limited Quote
As of Dec 31, 2017, total assets came in at $463.5 billion (RMB 2,897 billion), up 7.4% from year-end 2016.
As of Dec 31, 2017, total liabilities came in at $411.5 billion (RMB 2,572 billion), up 7.7% from year-end 2016.
As of Dec 31, 2017, total shareholders’ equity came in at $51.4 billion (RMB 321 billion), up 5.66% from year-end 2016.
The board of directors has recommended a final dividend payment of 6.4 cents (RMB 0.40) per share (inclusive of tax). This proposal is subject to the approval at the 2017 Annual General Meeting to be held on Jun 6, 2018.
The company’s core and comprehensive solvency ratios reached 277.61% and 277.65%, respectively.
Zacks Rank and Performance of Other Multiline Insurers
China Life carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other players from the insurance industry having reported fourth-quarter earnings, the bottom line of Brown & Brown, Inc. BRO, MGIC Investment Corporation MTG and The Progressive Corporation PGR beat the respective Zacks Consensus Estimate.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Brown & Brown, Inc. (BRO) : Free Stock Analysis Report
China Life Insurance Company Limited (LFC) : Free Stock Analysis Report
MGIC Investment Corporation (MTG) : Free Stock Analysis Report
The Progressive Corporation (PGR) : Free Stock Analysis Report
To read this article on Zacks.com click here.